Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our
Experiences

a 2019

Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences

WEBEROVÁ, Dana, Pavel WEBER, Hana MATĚJOVSKÁ KUBEŠOVÁ, Katarína BIELAKOVÁ, Vadim PRUDIUS et. al.

Základní údaje

Originální název

Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences

Název česky

Kazuistiky retroperitoneálního hematomu ve stáří - naše zkušenosti

Název anglicky

Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences

Autoři

WEBEROVÁ, Dana, Pavel WEBER, Hana MATĚJOVSKÁ KUBEŠOVÁ, Katarína BIELAKOVÁ a Vadim PRUDIUS

Vydání

15th EUGMS International Congress of the European Geriatric Medicine Society, 2019

Další údaje

Typ výsledku

Konferenční abstrakt

Utajení

není předmětem státního či obchodního tajemství

Klíčová slova česky

retroperitoneální hematom - krvácení - antikoagulační léčba - stáří

Klíčová slova anglicky

retroperitoneal hematoma - bleeding - anticoagulants - Old Age

Příznaky

Mezinárodní význam

Změněno: 9. 2. 2020 13:52, MUDr. Dana Weberová

Anotace

V originále

Introduction: As life expectancy gets longer the prevalence of cardiovascular diseases which require an anticoagulant drug therapy increases. Old people are of higher risk of evolving side effects (bleeding in particular) than the middle-aged population. Bleeding in the retroperitoneal space represents the life-threatening status and increases morbidity and mortality of patients. Methods: We present five cases of retroperitoneal bleeding while the coagulant drugs were administered – warfarin or low molecular weight heparin. There was not found any history of falls or injuries in recent period (30 days) before the occurence of bleeding. Results: All of our diseased were affected by significant polymorbidity. In one case the senior patient was admitted for the retroperitoneal hematoma, in the rest of the cases the bleeding was discovered during the institutionalization. In all cases we diagnosed bleeding in the retroperitoneal space with the impairment of the right or left iliopsoas muscle, alternatively perirenal space. Four of our diseased were treated conservatively adjusting the coagulation panels, one was treated surgically. Four patients survived and one patient deceased. Conclusion: The resolution of retroperitoneal bleeding in seniors should be strictly individual guided by a multidisciplinary medical team. Comorbidities, age, ability and frailty of the patient should be considered in each case. In the course of acute decompensation of internal diseases the coagulation blood test should be performed more frequently while administering the anticoagulants.

Citovat

WEBEROVÁ, Dana, Pavel WEBER, Hana MATĚJOVSKÁ KUBEŠOVÁ, Katarína BIELAKOVÁ a Vadim PRUDIUS. Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences. In 15th EUGMS International Congress of the European Geriatric Medicine Society. 2019.

@proceedings{1619350,
   author = {Weberová, Dana and Weber, Pavel and Matějovská Kubešová, Hana and Bielaková, Katarína and Prudius, Vadim},
   booktitle = {15th EUGMS International Congress of the European Geriatric Medicine Society},
   keywords = {retroperitoneal hematoma - bleeding - anticoagulants - Old Age},
   title = {Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences},
   year = {2019}
}

TY  - CONF
ID  - 1619350
AU  - Weberová, Dana - Weber, Pavel - Matějovská Kubešová, Hana - Bielaková, Katarína - Prudius, Vadim
PY  - 2019
TI  - Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences
KW  - retroperitoneal hematoma - bleeding - anticoagulants - Old Age
N2  - Introduction: As life expectancy gets longer the prevalence of cardiovascular diseases which require an anticoagulant drug therapy increases. Old people are of higher risk of evolving side effects (bleeding in particular) than the middle-aged population. Bleeding in the retroperitoneal space represents the life-threatening status and increases morbidity and mortality of patients. Methods: We present five cases of retroperitoneal bleeding while the coagulant drugs were administered – warfarin or low molecular weight heparin. There was not found any history of falls or injuries in recent period (30 days) before the occurence of bleeding. Results: All of our diseased were affected by significant polymorbidity. In one case the senior patient was admitted for the retroperitoneal hematoma, in the rest of the cases the bleeding was discovered during the institutionalization. In all cases we diagnosed bleeding in the retroperitoneal space with the impairment of the right or left iliopsoas muscle, alternatively perirenal space. Four of our diseased were treated conservatively adjusting the coagulation panels, one was treated surgically. Four patients survived and one patient deceased. Conclusion: The resolution of retroperitoneal bleeding in seniors should be strictly individual guided by a multidisciplinary medical team. Comorbidities, age, ability and frailty of the patient should be considered in each case. In the course of acute decompensation of internal diseases the coagulation blood test should be performed more frequently while administering the anticoagulants.
ER  -

WEBEROVÁ, Dana, Pavel WEBER, Hana MATĚJOVSKÁ KUBEŠOVÁ, Katarína BIELAKOVÁ a Vadim PRUDIUS. Clinical Cases Of Retroperitoneal Hematoma In Old Age – Our Experiences. In \textit{15th EUGMS International Congress of the European Geriatric Medicine Society}. 2019.

Podrobný výpis o publikaci